Ignite Creation Date:
2024-05-06 @ 4:54 PM
Last Modification Date:
2024-10-26 @ 2:18 PM
Study NCT ID:
NCT05121103
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2024-06-03
First Post:
2021-10-18
Brief Title:
A Study of the Safety Tolerability and Effectiveness of EZM0414 Investigative Product in Participants With RelapsedRefractory Multiple Myeloma and RelapsedRefractory Diffuse Large B Cell Lymphoma
Sponsor:
Epizyme Inc
Organization:
Ipsen
Organization Data
Organization:
Ipsen
Class:
INDUSTRY
Study ID:
SET-101
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Epizyme Inc
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None